v3.25.1

Segment information

12 Months Ended

Dec. 31, 2024

Segment information

Segment information

6. Segment information

We currently operate as a single operating segment.

GEOGRAPHICAL INFORMATION

In 2022, 2023 and 2024, our continuing operations were mainly located in Belgium, France, the Netherlands, Switzerland and United States. The revenues from our collaboration partner Gilead represented 87% of our total net revenues from continuing operations in 2024 (nearly 100% in 2023, 99.9% in 2022). The remaining 13% of the net revenues in 2024 consisted of supply revenues of Jyseleca® products to Alfasigma (Italy). The revenues in the entity’s country of domicile are not material.

Following table summarizes the net revenues by destination of customer:

​

​	​	​	​	​	​	​	​	​	​
​	​	Year ended December 31,
​		2024			2023			2022
​	​	(Euro, in thousands)
United States of America	​	€	266,588	​	€	665,174	​	€	414,129
Europe	​	​	46,577	​	​	118,354	​	​	91,151
Total net revenues	​	€	313,165	​	€	783,528	​	€	505,280
​	​	​	​	​	​	​	​	​	​
minus:	​	​	​	​	​	​	​	​	​
United States of America	​	€	25,802	​	€	425,466	​	€	172,980
Europe	​	​	11,714	​	​	118,338	​	​	91,051
Total net revenues from discontinued operations	​	€	37,516	​	€	543,804	​	€	264,031
​	​	​	​	​	​	​	​	​	​
United States of America	​	€	240,786	​	€	239,708	​	€	241,149
Europe	​	​	34,863	​	​	16	​	​	100
Total net revenues from continuing operations	​	€	275,649	​	€	239,724	​	€	241,249

​

On December 31, 2024, we held €357.8 million of property, plant and equipment, intangible assests and goodwill (€323.8 million in 2023; €370.4 million in 2022) distributed as follows:

​

​	​	​	​	​	​	​	​	​	​
​	​	December 31,
​		2024			2023			2022
​	​	​	(Euro, in thousands)
Belgium	​	€	95,686	​	€	56,209	​	€	72,087
France	​	​	5	​	​	1,438	​	​	20,397
The Netherlands	​	​	239,454	​	​	251,230	​	​	255,461
Switzerland	​	​	92	​	​	3,247	​	​	4,962
Spain	​	​	—	​	​	—	​	​	3,037
United States of America	​	​	22,533	​	​	11,660	​	​	12,729
Other	​	​	—	​	​	—	​	​	1,747
Total non-current assets	​	€	357,770	​	€	323,784	​	€	370,420

​

X

- Definition

The entire disclosure for operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2024-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfOperatingSegmentsAbstract
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration